Key result
Persistent type 2 endoleak after EVAR is linked to ~214% higher type 1A endoleak risk.
Why the study?
It was unknown whether achieved sealing length at first postoperative CTA and subsequent changes over time, along with persistent type 2 endoleak, are associated with later type 1A endoleak after infrarenal endovascular aortic repair.
Do sealing length dynamics and persistent type 2 endoleak predict later type 1A endoleak in patients after infrarenal endovascular aneurysm repair?
Cohort (n=501)
Do sealing length dynamics and persistent type 2 endoleak predict later type 1A endoleak in patients after infrarenal endovascular aneurysm repair?
Hazard Ratio: 3.14
p-value: p=0.008
Postoperative sealing length dynamics and persistent type 2 endoleaks are significant predictors of late type 1A endoleaks after infrarenal EVAR, highlighting the importance of longitudinal CTA surveillance.
SL changes may flag EL1A risk after EVAR; leaves open whether optimizing sealing length alters outcomes.
Aim: To determine whether achieved sealing length (SL) at the first postoperative computed tomography angiography (CTA) and its subsequent change over time are associated with later endoleak type 1A (EL1A) after infrarenal endovascular aortic repair. Secondary aims were to describe longitudinal remodeling of SL and to assess the association between persistent type 2 endoleak (EL2) and SL trajectories. Methods: This retrospective study analyzed SL and sealing surface measured on postoperative CTA, using the first postoperative CTA as the reference examination. We examined whether the first postoperative seal, its subsequent change over time, and prior persistent EL2 were associated with later EL1A. Trajectories of ΔSL and Δsealing surface were modeled using spline mixed-effects models. Time to EL1A was analyzed using Cox models with predictors at the first CTA and pre-event change, including a joint baseline-plus-change model. Landmark analyses were used to assess sealing behavior and EL1A risk. Type 2 endoleak was treated as a time-varying exposure, and its association with subsequent EL1A was evaluated using landmark Cox analyses at 12, 24, 36, and 60 months. Results: Among 501 patients, 346 were included in the longitudinal cohort; after a median follow-up time of 56 months (interquartile range, 28–95 months), 73 developed EL2, 39 developed EL1A, and 8 experienced both events. Baseline sealing at the first postoperative CTA and sealing deterioration were independently associated with EL1A in joint models (SL and sealing surface). Type 2 endoleak was associated with differential SL remodeling (interaction P < .001), with progressive divergence after ~24 months. In exploratory landmark analyses, EL2 was associated with higher subsequent EL1A hazard (36-month hazard ratio [HR] = 2.48; P = .030; 60-month HR = 3.14; P = .008), persisting after adjustment for sealing state and change up to the landmark. Conclusions: Both the first postoperative infrarenal seal and its variation during follow-up were associated with later EL1A. Persistent EL2 was associated with sealing deterioration, whereas its association with subsequent EL1A should be considered exploratory because few patients experienced both events. Clinical Impact In infrarenal endovascular aneurysm repair, both the sealing length achieved at the first postoperative computed tomography angiography and its longitudinal change were associated with later type 1A endoleak (EL1A). Persistent type 2 endoleak was associated with less favorable sealing evolution and may identify patients with reduced seal stability and exploratory higher subsequent EL1A risk.
No takes yet. Share an insight, caveat, or question.
Accarino et al. (2026) conducted a cohort in Infrarenal endovascular aneurysm repair (n=501). Persistent type 2 endoleak (EL2) vs. No persistent type 2 endoleak was evaluated on Later endoleak type 1A (EL1A) (HR 3.14, p=0.008). Persistent type 2 endoleak after infrarenal endovascular aneurysm repair was associated with a higher subsequent hazard of type 1A endoleak at 60 months (HR 3.14; P=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: